共 85 条
[1]
Beghi E(2019)Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Lancet Neurol 18 357-375
[2]
Giussani G(2010)Definition of refractory epilepsy: defining the indefinable? Lancet Neurol 9 27-29
[3]
Nichols E(2004)EEG and ECG in sudden unexplained death in epilepsy Epilepsia (Series 4) 45 338-345
[4]
Abd-Allah F(2008)Exercise, diet, health behaviors, and risk factors among persons with epilepsy based on the California Health Interview Survey, 2005 Epilepsy Behav 13 307-315
[5]
Abdela J(2008)The global burden and stigma of epilepsy Epilepsy Behav 12 540-546
[6]
Abdelalim A(2017)The burden of severely drug-refractory epilepsy: a comparative longitudinal evaluation of mortality, morbidity, resource use, and cost using German health insurance data Front Neurol 8 712-141
[7]
Kwan P(2015)Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: a potential role for infantile spasms and Lennox–Gastaut syndrome Epilepsy Behav 47 138-278
[8]
Brodie MJ(2016)Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial Lancet Neurol 15 270-2020
[9]
Nei M(2017)Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome N Engl J Med 376 2011-340
[10]
Ho RT(2017)An Australian nationwide survey on medicinal cannabis use for epilepsy: history of antiepileptic drug treatment predicts medicinal cannabis use Epilepsy Behav 70 334-1811